ArticleTrials2023

PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy.

Christele Le Gouill-Jaijarat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.